Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre.

导出 LinkOut

翻译打印收藏纠错

作者： Sue,Cheeseman ^[1] ; Matthew,Thompson ^[1] ; Will,Sopwith ^[1] ; Paul,Godden ^[2] ; Divyagiri,Seshagiri ^[1] ; Lola,Adedokun ^[2] ; Kieran,Zucker ^[3] ; Sunjay,Jain ^[3] ; Sanjeev,Kotwal ^[1] ; Stephen,Prescott ^[1] ; Ann,Henry ^[1] ; Joji,Joseph ^[1] ; Sameer,Chilka ^[1] ; Jo-An,Roulson ^[1] ; Michael,Weston ^[1] ; Simon,Burbidge ^[1] ; Simon,Brown ^[1] ; Satinder,Jagdev ^[1] ; Christy,Ralph ^[4] ; Geoff,Hall ^[1] ; Naveen S,Vasudev ^[1]

作者单位： Leeds Cancer Centre, St James's University Hospital, Leeds, United Kingdom. ^[1] IQVIA, London, United Kingdom. ^[2] Janssen Pharmaceuticals, Wycombe, United Kingdom. ^[3] Bradford Royal Infirmary, Bradford, United Kingdom. ^[4] School of Medicine, University of Leeds, Leeds, United Kingdom. ^[5]

关键词 carboplatin chemotherapy cisplatin real-world urothelial cancer

DOI 10.3389/fonc.2020.00167

PMID 32154169

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2020年10卷

167页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Current Treatment and Outcomes Benchmark for Locally Advanced or Metastatic Urothelial Cancer From a Large UK-Based Single Centre.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除